ImpactLife announces new Chief Medical Officer; Dr. Louis Katz transitions to emeritus status
(May 12, 2022 | Davenport, Iowa) –ImpactLife announces the appointment of Daniela Hermelin, M.D. as its Chief Medical Officer. Dr. Hermelin will begin her role as Chief Medical Officer as Dr. Louis Katz transitions to emeritus status, effective July 1, 2022. Dr. Hermelin is currently an Assistant Professor of Pathology at St. Louis University School of Medicine and the Medical Director of Transfusion Services at SSM Health St.